Literature DB >> 9576454

Risk factors associated with chronic hepatitis C virus infection: limited frequency of an unidentified source of transmission.

S L Flamm1, R A Parker, S Chopra.   

Abstract

OBJECTIVES: Risk factors have been studied in patients with acute non-A, non-B hepatitis, and approximately 40-50% have no known risk factor for viral acquisition. A significant undefined source of viral transmission has been suggested. We sought to clearly delineate the risk factors in a population of patients with documented chronic hepatitis C virus (HCV) infection to assess the magnitude of HCV transmission without known risk factors.
METHODS: Risk factor profiles were carefully assessed in 301 consecutive patients with chronic HCV infection. Patients were classified by gender and age. Overall risk factor distributions were calculated and comparisons were made between groups to detect differences in mode of HCV acquisition.
RESULTS: One hundred ninety-six men and 105 women were studied; 223 were age < or = 45 yr and 78 were > 45 yr. Overall, 25% of patients had a history of transfusion and 49% had a history of intravenous drug use (i.v.DU). Only 12% had no history of risk factor exposure. Men were more likely to have a history of i.v.DU and less likely to have a history of blood transfusion or sexual exposure/household contact. Younger patients were more likely to have a history of i.v.DU and older patients were more likely to have a history of blood transfusion and to deny all risk factor exposure.
CONCLUSIONS: A careful history delineated a potential risk factor for HCV acquisition in 88% of patients with chronic HCV infection. Men and younger patients had different risk factor profiles than women and older patients, respectively. It is likely that an important unknown mode of HCV transmission occurs in a significant minority of patients.

Entities:  

Mesh:

Year:  1998        PMID: 9576454     DOI: 10.1111/j.1572-0241.1998.171_b.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  10 in total

1.  The epidemiology of hepatitis C in a UK health regional population of 5.12 million.

Authors:  A H Mohsen
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

Review 2.  Management of chronic hepatitis C.

Authors:  V Lo Re; J R Kostman
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

Review 3.  Peginterferon-alpha-2a (40kD) plus ribavirin: a review of its use in hepatitis C Virus And HIV co-infection.

Authors:  Greg L Plosker; Gillian M Keating
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Known and probable risk factors for hepatitis C infection: a case series in north-eastern Poland.

Authors:  Sławomir Chlabicz; Robert Flisiak; Anna Grzeszczuk; Oksana Kovalchuk; Danuta Prokopowicz; Lech Chyczewski
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

5.  Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug use.

Authors:  Courtney L C Collins; Thomas Kerr; Laura M Kuyper; Kathy Li; Mark W Tyndall; David C Marsh; Julio S Montaner; Evan Wood
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

6.  Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.

Authors:  Benedikt Fischer; Emma Haydon; Jürgen Rehm; Mel Krajden; Jens Reimer
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

7.  The prevalence of HCV antibodies in skin disease patients in Saudi Arabia.

Authors:  Mona Halawani; Amal Balbisi; Hend Alotaibi; Fahed Alsaif; Talal M Bakir
Journal:  Saudi Pharm J       Date:  2009-12-24       Impact factor: 4.330

8.  Estimating the number of injecting drug users in Scotland's HCV-diagnosed population using capture-recapture methods.

Authors:  S A McDonald; S J Hutchinson; C Schnier; A McLeod; D J Goldberg
Journal:  Epidemiol Infect       Date:  2013-03-22       Impact factor: 4.434

9.  Risk factors for hepatitis C infection among sexually transmitted disease-infected, inner city obstetric patients.

Authors:  Youyin Choy; Lisa Gittens-Williams; Joseph Apuzzio; Joan Skurnick; Carl Zollicoffer; Peter G McGovern
Journal:  Infect Dis Obstet Gynecol       Date:  2003

10.  Detection of hepatitis C virus in the nasal secretions of an intranasal drug-user.

Authors:  James M McMahon; Malgorzata Simm; Danielle Milano; Michael Clatts
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-05-07       Impact factor: 3.944

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.